Company Information & Drug Savings for Ipsen Biopharmaceuticals, Inc. Medications
Ipsen is a global specialty-driven biopharmaceutical company focused on oncology, neuroscience, and rare diseases. Key products include Somatuline (lanreotide) for neuroendocrine tumors and acromegaly, Dysport (abobotulinumtoxinA) for movement disorders and aesthetics, Onivyde (irinotecan liposomal) for pancreatic cancer, and Cabometyx (cabozantinib) for kidney and liver cancers. Ipsen’s targeted therapeutics address serious conditions with limited treatment options.


How to Contact Ipsen Biopharmaceuticals, Inc.
Browse Medications Manufactured by Ipsen Biopharmaceuticals, Inc.
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.




